Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-15

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial evaluating the safety and efficacy of efalizumab (Raptiva) in adult patients with plaque psoriasis involving the hands and/or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raptiva (efalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Psoriasis | Phase 4 | Status: COMPLETED